These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31912234)

  • 1. Clinical burden of severe respiratory syncytial virus infection during the first 2 years of life in children born between 2000 and 2011 in Scotland.
    Thwaites R; Buchan S; Fullarton J; Morris C; Grubb E; Rodgers-Gray B; Coutts J
    Eur J Pediatr; 2020 May; 179(5):791-799. PubMed ID: 31912234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Lanari M; Anderson EJ; Sheridan-Pereira M; Carbonell-Estrany X; Paes B; Rodgers-Gray BS; Fullarton JR; Grubb E; Blanken M
    Epidemiol Infect; 2020 Aug; 148():e170. PubMed ID: 32799945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.
    Fryzek JP; Martone WJ; Groothuis JR
    Adv Ther; 2011 Mar; 28(3):195-201. PubMed ID: 21327753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs.
    Roy Á; Polazzi S; Ploin D; Gillet Y; Javouhey E; Lina B; ; Myard-Dury AF; Couray-Targe S; Duclos A; Casalegno JS
    Vaccine; 2023 Jun; 41(25):3796-3800. PubMed ID: 37198017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis.
    Hon KL; Leung TF; Cheng WY; Ko NM; Tang WK; Wong WW; Yeung WH; Chan PK
    J Crit Care; 2012 Oct; 27(5):464-8. PubMed ID: 22227087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
    Anderson EJ; DeVincenzo JP; Simões EAF; Krilov LR; Forbes ML; Pannaraj PS; Espinosa CM; Welliver RC; Wolkoff LI; Yogev R; Checchia PA; Domachowske JB; Halasa N; McBride SJ; Kumar VR; McLaurin KK; Rizzo CP; Ambrose CS
    Am J Perinatol; 2020 Mar; 37(4):421-429. PubMed ID: 30991438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.
    Hardelid P; Verfuerden M; McMenamin J; Smyth RL; Gilbert R
    Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.
    Anderson EJ; Carbonell-Estrany X; Blanken M; Lanari M; Sheridan-Pereira M; Rodgers-Gray B; Fullarton J; Rouffiac E; Vo P; Notario G; Campbell F; Paes B
    Pediatr Infect Dis J; 2017 Feb; 36(2):160-167. PubMed ID: 27755464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.
    Suh M; Movva N; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S195-S212. PubMed ID: 35968876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.
    Li Y; Johnson EK; Shi T; Campbell H; Chaves SS; Commaille-Chapus C; Dighero I; James SL; Mahé C; Ooi Y; Paget J; van Pomeren T; Viboud C; Nair H
    Lancet Respir Med; 2021 Feb; 9(2):175-185. PubMed ID: 32971018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.
    Kang JM; Lee J; Kim YK; Cho HK; Park SE; Kim KH; Kim MJ; Kim S; Kim YJ
    Pediatr Int; 2019 Jul; 61(7):688-696. PubMed ID: 31107995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
    Thorburn K
    Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS).
    Fergie J; Suh M; Jiang X; Fryzek JP; Gonzales T
    J Infect Dis; 2022 Apr; 225(7):1197-1204. PubMed ID: 32691037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
    Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
    Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.
    Kong AM; Krilov LR; Fergie J; Goldstein M; Diakun D; Wade SW; Pavilack M; McLaurin KK
    Am J Perinatol; 2018 Jan; 35(2):192-200. PubMed ID: 28881376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus (RSV) infection in children with medical complexity.
    Lim A; Butt ML; Dix J; Elliott L; Paes B
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):171-176. PubMed ID: 30374685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan.
    Chi H; Chung CH; Lin YJ; Lin CH
    PLoS One; 2018; 13(5):e0197410. PubMed ID: 29746578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries.
    Wang X; Li Y; Vazquez Fernandez L; Teirlinck AC; Lehtonen T; van Wijhe M; Stona L; Bangert M; Reeves RM; Bøås H; van Boven M; Heikkinen T; Klint Johannesen C; Baraldi E; Donà D; Tong S; Campbell H;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S22-S28. PubMed ID: 35023567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study.
    Priante E; Tavella E; Girardi E; Militello MA; Mardegan V; Maule MM; Dall'Agnola A; Baraldi E; Manzoni P
    Am J Perinatol; 2019 Jul; 36(S 02):S77-S82. PubMed ID: 31238365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.
    Suh M; Movva N; Jiang X; Reichert H; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S184-S194. PubMed ID: 35968879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.